NCT04633876

Brief Summary

The main purpose of this study is to understand the impact of lifestyle coaching on the risk of future cardiometabolic disease, workability and self-assessed wellbeing. The data gathered during the study helps in the future to better identify different focus groups for more tailored interventions. The study consists of two main stages: screening and coaching phase. Screening Aava and the pension will recruit 2000 participants for screening from the employer companies. Screening participants are invited to answer a wellbeing questionnaire (Aava Virta questionnaire, Work Ability Index questionnaire) and give blood samples and physiological measurements, including weight, height, waist circumference, neck circumference and blood pressure. All subjects participating in screening will receive the results from wellbeing questionnaire immediately and they receive the results from blood test within few weeks. Of these 2000 screened persons, a total of 300 high-risk (according to ApoB/ApoA1) individuals and 600 medium-risk individuals will be selected to participate in the coaching phase. These participants are randomly split into treatment and control groups, so that eventually 150 high-risk and 300 medium-risk individuals are placed in both groups. Therefore, a total of 900 subjects carry forward to the coaching phase and in 1100 subjects the study ends. All 900 subjects entering coaching phase receive home a Firstbeat Bodyguard 2 device with instructions for performing Firstbeat wellbeing analysis. After the measurement the device is posted back for analysis according to instructions. The results and feedback from this test is received in the end of the study after the coaching phase. Stage 2: Coaching phase Within the coaching groups, participants in the high-risk category and treatment group undergo an individual coaching program. Participants in the medium-risk category undergo a group coaching program with similar aims. Both coaching programs last 10 weeks during which there are 8 almost weekly coaching sessions at the subjects worksite or near vicinity. Both coaching programs aim in reducing cardiometabolic risk factors and improving subjective well-being. The topics of the lifestyle coaching are 1) nutrition, 2) physical activity, 3) sleep and stress and 4) the long-term maintenance of lifestyle changes. The aims and methods in each coaching topic is based on Finnish recommendations on the topic. The coaching sessions include mostly discussions but in the sessions focusing more on physical activity there are also sessions including activity. In the halfway (5 weeks) of coaching phase, a second blood sampling and Aava wellbeing questionnaire are taken from all subjects (both coaching and control groups). In the end of the coaching phase (10 weeks) blood samples, Aava wellbeing questionnaire, Work Ability Index -questionnaire and physiological measurements are taken the last time. At this stage a second Firstbeat analysis is also performed. BBI-15 questionnaire is administered before and after the coaching phase. An open ended questionnaire regarding lifestyle change motivators and experiences before, during and after the coaching phase is administered to all participants. Also, a small subset (20 persons) of subjects takes in interviews to delve more detailed to the experiences during the study. End of coaching phase and study - start of feedback and analysis After the coaching phase has ended and the subjects (coaching and their control groups) have received all the results (wellbeing questionnaire, blood tests and Firstbeat results) for the study and feedback sessions will be held for all. Willing subjects also receive the results from the gene test in form of PRS scores ie. total genetic risk for three areas of health: heart disease, type 2 diabetes and obesity. THL gene results do not identify single gene variants. After this feedback session the study has ended for the subject. After all data in the study has been gathered starts the analysing and reporting phase for the researchers. At this stage the researchers can retrieve data from Aava patient records to analyse the effect of earlier diagnoses and findings. The information retrieved relate to ICD-10 diagnosis codes C00-C97 (malignant neoplasms), E00-E89 (endocrine, nutritional and metabolic diseases), F00-F99 (mental, behavioral and neurodevelopmental disorders), I00-I99 (diseases of the circulatory system) and M00-M99 (diseases of the musculoskeletal system and connective tissue) as these diagnostic codes can be important background factors for biomarkers of CVD and Type 2 diabetes risk and to some of the secondary endpoints like workability.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 15, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 19, 2020

Completed
6 months until next milestone

First Posted

Study publicly available on registry

November 18, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

November 18, 2020

Status Verified

November 1, 2020

Enrollment Period

1.3 years

First QC Date

May 19, 2020

Last Update Submit

November 16, 2020

Conditions

Outcome Measures

Primary Outcomes (4)

  • ApoB/ApoA1

    Ratio of ApoB to ApoA1 concentration

    10 weeks

  • hs-CRP

    Measure of low-grade inflammation

    10 weeks

  • TG

    Fasting triglyceride levels

    10 weeks

  • Fasting blood glucose

    Fasting blood glucose

    10 weeks

Secondary Outcomes (6)

  • Workability

    10 weeks

  • Work disability

    10 weeks

  • Blood pressure, both systolic and diastolic

    10 weeks

  • Waist circumference

    10 weeks

  • Heart Rate Variability

    10 weeks

  • +1 more secondary outcomes

Study Arms (3)

Control group

ACTIVE COMPARATOR

The subjects allocated to this group receive some results from baseline measurements (as do subjects in the intervention) but do not receive lifestyle counselling

Other: Control group

Individual coaching

EXPERIMENTAL

These subjects receive individual counselling during the study.

Behavioral: Individual coaching

Group coaching

EXPERIMENTAL

These subjects receive individual counselling during the study.

Behavioral: Group coaching

Interventions

Individual coaching on lifestyle change, sleep, nutrition, physical activity and stress management.

Individual coaching
Group coachingBEHAVIORAL

Group coaching on lifestyle change, sleep, nutrition, physical activity and stress management.

Group coaching

Group receives no lifestyle coaching but did get baseline results from assessments which might motivate for lifestyle change.

Control group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signed written informed consent
  • Age 18 - 65 years
  • Male or female with at least 1/3 of each gender
  • Adequate Finnish or English\* skill to comprehend study-related instructions and questionnaires

You may not qualify if:

  • Suspected high probability to travel for more than one working day a week during the trial period according to the investigator's assessment
  • History of a major cardiovascular event (myocardial infarction, coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI), stroke, or transient ischemic attack) within the previous 6 months
  • Diagnosed type 1 or type 2 diabetes requiring treatment
  • History of malignant disease such as cancer within five years prior to recruitment
  • Lipid-lowering medication (such as any statin or ezetimibe) or medication for obesity (such as orlistat or liraglutide)
  • Pregnancy
  • Use of cardiac pacemaker or history of atrial fibrillation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aava Medical

Helsinki, 00100, Finland

Location

Related Publications (1)

  • Shiri R, Vaananen A, Mattila-Holappa P, Kauppi K, Borg P. The Effect of Healthy Lifestyle Changes on Work Ability and Mental Health Symptoms: A Randomized Controlled Trial. Int J Environ Res Public Health. 2022 Oct 13;19(20):13206. doi: 10.3390/ijerph192013206.

MeSH Terms

Conditions

Occupational StressMetabolic SyndromeLipid Metabolism DisordersRisk Reduction BehaviorBurnout, Psychological

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Occupational DiseasesStress, PsychologicalBehavioral SymptomsBehaviorInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Eira Roos, PhD

    Aava Medical

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
FACTORIAL
Model Details: RCT, lifestyle coaching in two arms: individualised coaching and group coaching. No coaching as a control group.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2020

First Posted

November 18, 2020

Study Start

February 15, 2020

Primary Completion

June 1, 2021

Study Completion

September 1, 2021

Last Updated

November 18, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will share

Locations